Development and in-vitro, in-vivo evaluation of Pioglitazone-loaded polymeric nanoparticles using central composite design surface response methodology

• Hoofdauteurs: Dinesh Kumar Sharma (Auteur), Gurudutta Pattnaik (Auteur), Amulyaratna Behera (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2023-05-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Pioglitazone is a type 2 diabetes drug encapsulated in polymeric nanoparticles using solvent evaporation techniques. In this study, the drug-polymer ratio (A), stirring speed (B), and stirring time (C) were three process parameters that were optimized using a three-factor, three-level Central Compos...